Application | Comment | Organism |
---|---|---|
medicine | The absence of CaGAL10 alone does not significantly reduce virulence in mouse model studies, but since it leads to increased drug sensitivity, it can be explored as a potential drug target in combination with other candidacidal drugs. Thus the UDP-galactose-4-epimerase plays an important role in the biology of the human pathogen, Candida albicans, like in the case of several other pathogens. | Candida albicans |
Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
---|---|---|---|
75480 | - |
- |
Candida albicans |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
UDP-galactose | Candida albicans | glycolysis and TCA cycle, Leloir pathway | UDP-glucose | - |
? | |
UDP-galactose | Schizosaccharomyces pombe | glycolysis and TCA cycle, Leloir pathway | UDP-glucose | - |
r |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Candida albicans | - |
- |
- |
Schizosaccharomyces pombe | Q9HDU3 | - |
- |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
UDP-galactose | glycolysis and TCA cycle, Leloir pathway | Candida albicans | UDP-glucose | - |
? | |
UDP-galactose | glycolysis and TCA cycle, Leloir pathway | Schizosaccharomyces pombe | UDP-glucose | - |
r |
Synonyms | Comment | Organism |
---|---|---|
CaGAL10 | - |
Candida albicans |
GAL10 | - |
Candida albicans |
UDP-galactose-4-epimerase | - |
Candida albicans |
UDP-galactose-4-epimerase | - |
Schizosaccharomyces pombe |